Prognostic Awareness and Patient-Physician Communication in Malignant Glioma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

95 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-31

Study Completion Date

2018-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn more about the understanding patients with brain tumors have of their disease and their communication with their physician. Ultimately, we hope to use these findings to improve communication between patients and their doctors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers

NCT02375841

Brain Cancer Glioblastoma

ACTIVE_NOT_RECRUITING

A Pilot Study of Using Video Images in Advance Care Planning in Malignant Glioma Patients

NCT00970788

Advanced Brain Cancer

COMPLETED NA

Quality of Life and Patient Needs in Advanced High Grade Gliomas

NCT05039346

Quality of Life Brain Tumor Glioblastoma +2 more

COMPLETED

A Family Study of Adults With Glioma

NCT00339352

Glioma

COMPLETED

Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery

NCT01417507

Adult Diffuse Astrocytoma Adult Mixed Glioma Adult Oligodendroglioma +4 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malignant Glioma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Malignant Glioma patients

This is a cross-sectional study of patients with MG who are admitted to the inpatient Neurology service at MSKCC. We anticipate that participants will be accrued over approximately 18-24 months. All patients with MG admitted to Neurology, will be screened for eligibility and willingness to participate in the study.

surveys and cognitive tests

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surveys and cognitive tests

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 18
* Diagnosis of any WHO grade III or IV glioma
* Admitted to the inpatient Neurology service
* Has had at least one outpatient visit with a neuro-oncologist at MSKCC Fluent in English

* Age greater than or equal to 18
* Identified by the patient as a relative, friend, or partner with whom he or she has a significant relationship and who provides him or her physical or emotional assistance.
* The patient has himself or herself agreed to participate in this study

Exclusion Criteria

* A patient will be excluded if the Glasgow Coma Scale is less than 15. The patient must be oriented to self, age, place, and year, and month.
* Aphasia precluding comprehension and verbalization of consent to participate
* Patients who cannot verbally demonstrate their understanding of the risks, benefits, and alternatives to participating in the study. This evaluation will take place for otherwise eligible and willing participants, and it will be performed by the NP or MD clinician who is obtaining informed consent and will be documented in the medical record.

* No eligible caregivers who can complete the brief assessment in person or via telephone will be excluded

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes